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Abstract
A functional allele of the mouse catechol-O-methyltransferase (Comt) gene is defined by the insertion of a B2 short interspersed
repeat element in its 39-untranslated region (UTR). This allele has been associated with a number of phenotypes, such as pain and
anxiety. In comparison with mice carrying the ancestral allele (Comt1), ComtB2i mice show higher Comt mRNA and enzymatic
activity levels. Here, we investigated themolecular geneticmechanisms underlying this allelic specific regulation ofComt expression.
Insertion of the B2 element introduces an early polyadenylation signal generating a shorter Comt transcript, in addition to the longer
ancestral mRNA. Comparative analysis and in silico prediction of Comt mRNA potential targets within the transcript 39 to the B2
element was performed and allowed choosing microRNA (miRNA) candidates for experimental screening:mmu-miR-3470a,mmu-
miR-3470b, and mmu-miR-667. Cell transfection with each miRNA downregulated the expression of the ancestral transcript and
COMT enzymatic activity. Our in vivo experiments showed thatmmu-miR-667-3p is strongly correlated with decreasing amounts of
Comt mRNA in the brain, and lentiviral injections of mmu-miR-3470a, mmu-miR-3470b, and mmu-miR-667 increase
hypersensitivity in the mouse formalin model, consistent with reduced COMT activity. In summary, our data demonstrate that the
Comt1 transcript contains regulatory miRNA signals in its 39-untranslated region leading to mRNA degradation; these signals,
however, are absent in the shorter transcript, resulting in higher mRNA expression and activity levels.
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1. Introduction
Dysregulation of catecholamine signaling has been implicated in
a variety of neurologic and neuropsychiatric disorders.20,27
Catechol-O-methyltransferase (COMT) is a critical enzyme in
catechol catabolism. O-methylation of biologically active amines,
such as epinephrine, norepinephrine, and dopamine, is a rate-
limited step controlling bioavailability of these neurotransmitters.18,33
COMT has been implicated in a number of critical functions such as
stress response,9,37 mood,60 and cognition.5 Furthermore, in recent
years, the essential role of COMT activity in pain processes has
become increasingly evident.22,49
Functional variability at the COMT gene locus has been
identified in both the human population and laboratory mouse
strains. It has been associated with responses to noxious
stimuli,2,12,13 chronic pain conditions,11,13,53 intermediate pain
phenotypes,11 and analgesics responding.56 In the human
population, functional single nucleotide polymorphisms (SNPs)
have been identified in the translated and untranslated regions
(UTRs) of COMT mRNA. In the UTRs, an SNP situated 39 to the
coding region (39-UTR) affects COMT transcript level,4 and an
SNP situated in the 59-UTR increases the efficiency of translation
through relaxing tertiary mRNA structure.61 In the coding region,
a number of variations have been established, representing
several molecular genetic mechanisms. The nonsynonymous
change of valine to methionine at codon 158 of COMT reduces
protein stability,31 and the interaction between synonymous and
nonsynonymous SNPs alters mRNA secondary structure leading
to reduced translation efficiency.41 For SNPs in the promoter
region ofCOMT gene locus, evidence for cis-acting influences on
mRNA expression also has been observed.4,41
Inmouse laboratory strains, the insertion of a type of transposon
termed B2 short interspersed element (SINE) in the 39-UTR of
Comt has been shown to be associated with decreased stress
response, decreased anxiety, and a decreased assortment of pain
phenotypes mediated by increased mRNA and protein
amounts.24,29,50 Overall, the presence of the B2 SINE element
significantly decreased sensitivity to noxious stimuli measured by
summation of 20 nociceptive assays,28 with largest contribution of
acute spontaneous inflammatory nociception.2,50,67
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Almost half of the laboratory mouse strains tested carry this
insertion and thus demonstrate increased Comt level. It has been
proposed that the B2 SINE insertion shortens the 39-UTR of the
mRNA by allowing utilization of an alternative polyadenylation
signal (PAS), a sequence of nucleotides that signals the transcript
to end with a poly (A) tail.24,29 However, the mechanisms
underlying the connection between a shorter Comt mRNA
39-UTR and increased mRNA and protein amounts have not
been identified. Indeed, it is unclear whether the shorter transcript
should be more abundant, and if so, what drives its higher level.
Here, we investigated and established the molecular genetic
mechanisms contributing to the B2 SINE–dependent upregula-
tion of Comt expression. We hypothesized that the 39-UTR of the
ancestral Comt mRNA (Comt1) contains regulatory signals
responsible for mRNA degradation that are absent in the shorter
alternative Comt mRNA isoform with the B2 SINE insertion.
2. Materials and Methods
2.1. Animal husbandry
All experiments adhered to guidelines set by the National Institutes
of Health (NIH) Guide for the Care and Use of Laboratory Animals
by the Canadian Council on Animal Care (CCAC) and were
approved by the Institutional Animal Care and Use Committees at
the University of North Carolina (UNC), the Genomics Institute of
the Novartis Research Foundation (GNF), and McGill University.
Mice at GNF and UNC-Chapel Hill were housed in specific
pathogen-free colonies and were maintained on a 12-hour
light–dark cycle. Standard high efficiency particulate air-filtered
polycarbonatemouse cages housed between 2 and 4mice. Every
cage held a cotton nestlet on Bed-o-cob bedding. Water and food
(Purina,USA)were available ad libitum.Mice atMcGill were housed
with their same-sex littermates (4 animals per cage) in standard
shoebox cages, maintained in a temperature-controlled (20˚C 6
1˚C) environment (14:10-hour light/dark cycle), and fed (Harlan
Teklad 8604) and watered ad libitum. Mice were assigned to
experimental conditions in a randomized fashion within the cage.
2.2. Inbred strains
The 29 strains tested were 129S1/SvImJ, A/J, AKR/J, BALB/
cByJ, BTBR T 1 tf/J, BUB/BnJ, C3H/HeJ, C57BL/6J, C57BR/
cdJ, C58/J, CBA/J, CE/J, DBA/2J, FVB/NJ, I/LnJ, KK/HlJ, MA/
MyJ, MRL/MpJ, NOD/LtJ, NON/LtJ, NZO/HlLTJ, NZW/LacJ,
P/J, PL/J, RIIIS/J, SJL/J, SM/J, SWR/J, and WSB/EiJ.
2.3. Collection of specific brain regions for Affymetrix
array data
Gene expression data were collected from the 29 mouse strains
listed above as part of the GNF initiative. The data were collected at
theGNFusing theAffymetrixGeneChip430v2whole-genomemouse
arrays. Mice of both sexes (8-10 weeks of age) were purchased from
the Jackson Laboratory (Bar Harbor, ME) and habituated for 1 week
before sacrificebycervical dislocationwithout anesthesia.Dissections
were performed between 0900 and 1130 hours. The regions
dissected were prefrontal cortex, amygdala, hypothalamus, hippo-
campus, nucleus accumbens, striatum, and pituitary gland. Brain
region dissections are described in more detail in Ref. 50.
2.4. Affymetrix array data: RNA, cDNA preparation, and gene
expression analysis
After dissection, tissues were placed in RNase-free micro-
centrifuge tubes, set on dry ice, and stored at 280˚C. Frozen
tissue was pulverized to a fine powder (tissue pulverizer; Cole-
Palmer, Vernon Hills, IL) in liquid nitrogen to obtain a homoge-
neous tissue sample. An aliquot was further homogenized in
TRIzol (Life Technologies, Carlsbad, CA) with a rotor–stator
homogenizer (Omni International, Kennesaw, GA). RNeasy
columns (Qiagen, Hilden, Germany) were used to purify total
RNA, and RNA integrity was assessed on a bioanalyzer (Agilent,
Santa Clara, CA). Pools of high-quality RNA from 3 mice per
strain, per sex, and per brain region were used to produce the
cDNA required for 1 microarray. The Affymetrix 1-cycle target
labeling kit was used to amplify and label the RNA used for each
Affymetrix GeneChip 430v2 whole-genome mouse array. Probe
sets 1449183_at and 1418701_at were used to analyze Comt
hybridization pattern in the coding and 39-UTR regions, re-
spectively. Gene expression was analyzed using standard
procedures,55 data were processed using the gcRMA algo-
rithm,65 and raw data deposited under series accession
GSE20160 in GEO (http://ncbi.nih.gov/geo). Z scores of the
Comt transcript in the coding region and 39-UTR region were
calculated using the formula z5 x2 x

s, where x5 individual strain
mean, x

5 group mean for all strains, and s5 SD across strains.
2.5. Cell constructs
Generation of the expression plasmids carrying the ancestral
allele (pComt1) or the B2 SINE insertion (pComtB2i) has been
described in detail previously.50 Briefly, expression plasmids have
been generated in pCMV-SPORT6 by Dr Oskar Laur at the
Custom Cloning Core Facility, Emory University. miExpress
precursor microRNA (miRNA) expression clones were purchased
from GeneCopoeia, Inc, Rockville, MD. The miRNA generating
vectors usedwere cloned in pEZX-MR04 under a CMV promoter.
The expression vectors were specific for mmu-miR3470a and
mmu-miR-3470b. As the prediction software did not specify
mmu-miR-667-3p or mmu-miR 667-5p, the precursor mmu-
miR-667, which makes both transcripts, was ordered. pEZX
without an insert was used as the empty vector control. All clones
were verified by sequencing the entire cDNA insert in both
directions. The full sequence of the clones can be found in
Supplementary Table 1 (available online as Supplemental Digital
Content at http://links.lww.com/PAIN/A116).
2.6. Cell transfection experiments: transfection, cDNA
preparation, enzymatic, and gene expression analysis
2.6.1. Transfection
A mouse leukemic monocyte macrophage cell line, RAW 264.7,
was transiently transfected into 24-well plates using TransIT-3T3
tranfection kit (Mirus, Madison WI) at a density of 50,000 cells per
milliliter of media, in accordance with manufacture’s recommen-
dations. To account for transfection efficiency, a control plasmid,
pSEAP2 (Clontech, Mountain View, CA), was kept at 10% of the
total plasmid DNA transfected. Cells were harvested 18 to 24
hours after transfection.
2.6.2. cDNA preparation
TRIzol (Life Technologies) was used to isolate whole RNA from
cell culture dishes, in accordance with the manufacturer’s
guidelines. Because expression constructs were added to the
cell culture, it was necessary to reduce plasmid contamination
from true cDNA signal. Turbo DNAse (Life Technologies) was
used with the manufacturer’s protocol in their rigorous DNAse
treatment protocol. A no reverse transcriptase control sample
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was prepared at the same time for each cDNA synthesis. cDNA
was synthesized using Superscript III (Life Technologies) in
accordance with the manufacturer’s instruction, using 500 ng
total RNA per 20 mL reaction.
2.6.3. Gene expression analysis
All q-polymerase chain reaction (PCR) datawere collected atUNC-
Chapel Hill on an Applied Biosystems (Waltham,MA) 7900HT real-
time PCR machine fitted with a 384-well reaction block (Life
Technologies). Taqman and SYBR green assays were run in
separate wells on the same plate. Polymerase chain reaction
cycling conditions are as follows: 40 cycles of 15 seconds at 95˚C
followed by 60 seconds at 60˚C, followed by a thermal melting
curve to ensure a single dissociation peak. The Comt transcript
was measured in the coding region using Taqman assay
Mm00514377_m1, using TaqMan Universal PCR Master Mix.
For the Comt 39-UTR region, we designed primers in the region
covered in theAffymetrix array probe set 1418701_at. Forward and
reverse primers for the 39-UTR amplimer are CTCACTAACTG-
GAAGAGGAGATTTTT and CATTCTTAAGATG AAATGTGG-
TATGA, respectively. SYBR Green Real-Time PCR Master Mix
(Life Technologies) was used according to the manufacturer’s
recommendations. Data were analyzed using the comparative
cycle threshold method,30 with the normalizing sample pComt1 or
pComt1 3 pmiR Empty Vector. Murine Mrpl19, Taqman assay
Mm00452754_m1, was used as the housekeeping gene. For
transfection efficiency, we measured the amount of Secreted
Alkaline Phosphatase (SEAP) transcript with SYBR Green, using
forward and reverse primers GCCGACCACTCCCACGTCTT and
CCCGCTCTCGCTCTCGGTAA, respectively.
2.6.4. Enzymatic analysis
The enzymatic protocol follows Tsao et al.,62 which quantifies
the amount of Comt enzymatic activity by the quantity of
radiolabeled catechol extracted from a lysate. To account for
transfection efficiency of the expression vectors into the cells,
the media were sampled immediately before harvesting the
cells and the SEAP assay was performed according to the
manufacturer’s recommendation. Samples with transfection
efficiencies below 40% of the highest SEAP value were not
used. After removing media, cells were washed with cold 1X
PBS. Each well was covered by 65 mL of enzymatic buffer,
composed of 10 mM Tris (pH 7.4), 1 mMMgCl2, and 1 mMDTT,
and frozen overnight at 280˚C. Plates were thawed a single
time on ice, lysates collected, and cell lysis confirmed by
visualization in the Cellometer (Nexcelom, Lawrence, MA).
Lysates were normalized in enzymatic buffer for protein content
using a BCA assay. Eighty microliters of an enzymatic master
mix was added to 20 mL of normalized lysates in enzymatic
buffer. The Master Mix is an enzymatic buffer with 10 mM
catechol (Fisher Scientific, Waltham, MA), dissolved in H2O,
and S-[methyl-3H]-adenosyl-L-methionine (10.0 Ci/mmol; Per-
kinElmer). The strip tubes were incubated in a PCRmachine for
20 minutes at 37˚C, and the reaction terminated with 100 mL of
1 M HCl, pipetted into each well with a multichannel pipette.
Each 200 mL reaction was added to 10 mL scintillation fluid
(Monoflow I; National Diagnostics Hessle, United Kingdom),
vortexed briefly, and quantified using a scintillation counter.
The range of the assay was determined in each experiment by
a serial dilution of one of the lysates to generate a linear curve of
scintillation values. The scintillation values were then normal-
ized by the empirically determined SEAP multiplier.
2.6.5. Data analysis
Each experiment had between 2 and 4 technical replicates, and
at least 3 experiments were conducted on 3 separate days.
Results are expressed asmean6 SEM, from combining Z scores
from individual experiments. Statistical significance was de-
termined using GraphPad Prism, version 5.01 for Windows
(GraphPad Software, San Diego, CA), 1-tailed, nonpaired,
Student’s t test.
2.6.6. Prediction of microRNA targets
Taking into account experimental evidence that AGO-bound
target sites show strong structural accessibility,63 as well as
miRNA target accessibility patterns from prior computational
predictions,51 we considered predicted target sites located in the
“open” regions of the mRNA, where mRNA folding stability is not
low, that is, the local secondary structuremight be easily unfolded
and does not significantly influence target site accessibility.51,63
We analyzed RNA local secondary structures in full-length 39-
UTR, in the downstream region of the early PAS in ComtB2i
transcripts, as well as in B2 SINE region and B1 repeat region,
also situatedwithin 39-UTRofComt1mRNA. The local secondary
structure was predicted by the Afold software,43 and the free
energy of the target site accessibility was estimated as described
earlier.51 The variability of RNA secondary structure predictions
was minimized by using local RNA folding with a short window
length (60 nucleotides) when estimating the accessibility of target
sites.35 Other features that are important for optimization of
miRNA-predicted targets are (1) the free energy of the duplex
between miRNA and mRNA targets and (2) a stable duplex in the
“seed” region containing a pairing pattern.58 The ThermoCom-
position software34 uses the following thresholds to predict stable
miRNA–mRNA duplexes: (1) duplex free energy #220 kcal/mol,
(2) seed dG # 210 kcal/mol, (3) seed length .8 nucleotides. In
our selection algorithm, we considered recent experimental
results on the location of optimal miRNA targets in 39-UTRs.63
For unique sequences that are not in the repeat regions, we also
used miRWalk program (http://mirwalk.uni-hd.de) to predict
miRNA targets in the area of interest.
We analyzed sequence conservation of the predicted target
sites between mouse and rat Comt 39-UTRs using the rat
genome downloaded from the University of California at Santa
Cruz genomeweb browser (http://genome.ucsc.edu). The Owen
sequence alignment tool25,43 was used to align the ancestral
mouse Comt 39-UTR sequences of the miRNA target sites to rat
sequences.
2.7. Collection of hippocampus, hypothalamus, and
amygdala for Comt and micro-RNA q-polymerase
chain reaction
After generation of cDNA array expression results, no additional
mRNA samples from the initial 29 mice strains were available for
measuring mmu-miRs. We then limited our q-PCR experiments
to the subset of 4 representative strains that were separately
purchased from the Jackson Laboratory. Furthermore, based on
the cDNA array expression analysis results, we concluded that
the molecular effect of the B2 SINE element was the same for
male and female mice (Fig. 2B). We thus carried out q-PCR
experiments to test the correlation between relative ComtmRNA
and mmu-miRs expression levels in male mice only, avoiding
contribution of the female estrous cycle to expression of Comt,
and thus reducing experimental SD.
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Ten-week-oldmalemicewere housed and habituated at UNC-
Chapel Hill as closely as possible to the protocol used at GNF.
Data were collected from 16 individual 10-week-old male mice, 4
from each strain: AKR/J, BALB/cByJ, C3H/HeJ, and SJL/J. To
increase the amount of available brain material, a region
containing the hippocampus, hypothalamus, and amygdala
(HHA) was dissected, and material from each mouse was kept
separately in an attempt to capture intrastrain diversity in gene
expression. Mice used for q-PCR experiments were sacrificed
according to the guidelines set by the Institutional Animal Care
and Use Committee (IACUC) at UNC-Chapel Hill.
2.8. Real-time polymerase chain reaction reagents and
assays using HHA brain tissue
2.8.1. Reverse transcription polymerase chain reaction for
Comt coding mRNA levels
All reagents were purchased from Life Technologies. For mouse
brain RNA isolation, the HHA sample from each animal was
collected and processed in the samemanner as brain material for
the Affymetrix array, up to the step of pulverizing the frozen tissue
sample. An aliquot of frozen powdered material was further
homogenized in TRIzol with a 16-gauge syringe, and total RNA
was isolated according to the manufacturer’s instructions. Total
RNA was treated with Turbo DNase. Comt coding region cDNA
was synthesized using the high-capacity cDNA reverse tran-
scription kit, using 500 ng total RNA per 20 mL reaction, per the
manufacturer’s protocol. A control sample without reverse
transcriptase (RT) enzyme was prepared at the same time for
each cDNA synthesis, to ensure against amplification from
plasmid or amplimer contamination. TaqMan Universal PCR
Master Mix was used for q-PCR, as per the manufacturer’s
protocol. Data were analyzed using the comparative cycle
threshold method,30 with data normalized to an arbitrarily
selected animal. Comt transcript was measured in the coding
region using Taqman assay Mm00514377_m1. Mouse Gapdh
was included as an endogenous control.
2.8.2. Reverse transcription polymerase chain reaction for
microRNA levels
All reagents were purchased from Life Technologies. For miRNA
isolation frommousebrain, the remainingmaterial fromeach frozen
pulverized HHA sample was used with the mirVana miRNA
isolation kit (Life Technologies) in accordance with the manufac-
turer’s recommendations. Both miRNA and whole RNA extraction
from brain were conducted as quickly as possible to avoid RNase
degradation, and each extraction was taken from a single HHA
aliquot per animal. To check RNA integrity, RNA preparationswere
run on an Agilent Bioanalyzer, as described previously. Taqman
probes were purchased for quantification of mmu-miRs: 667-3p,
667-5p, 3470a, 3470b, and snoRNA202 as an endogenous
control. TaqMan Universal PCR Master Mix without AmpErase
UNG was used according to the manufacturer’s protocol.
2.8.3. Data analysis
We determined the relative amount of Comt coding transcript
levels in 15 animals (4 from strains AKR/J, C3H/HeJ, and SJL/J,
and 3 from strain BALB/cByJ) normalized to an arbitrarily selected
animal from the C3H/HeJ strain, which then had a Comt
transcript value of 1.0. The fifteen other animals had Comt
coding transcript values between 0.9 and 2.5 times than that of
the arbitrarily selected animal. Normalization to the same
arbitrarily selected animal was also conducted for the miRNA
values, so that the amount of Comt transcript to amount of
miRNA transcript the arbitrarily selected animal would always be
1.0 to 1.0. A linear regression between each miRNA of interest
and amount of Comt transcript was then plotted using the
GraphPad Prism program (version 6.03), which calculated the r2
goodness of fit and the P value for significance.
2.9. Expression pattern of microRNAs in the published
data sets
The relative expression of mmu-miR-667-3p, -667-5p, -3470a,
and -3470b, acrossmouse tissues and cells was estimated using
the following published RNA-seq data sets: brain, testis, ovary,
spleen, bone marrow, skin, salivary glands, whole body, embryo,
and mouse NIH-3T3 fibroblastoma cell line.7
2.10. Lentiviral injection of microRNAs and formalin testing
Purified lentiviral particles for miRNA (mmu-miR-3470a, mmu-
miR-3470b, and mmu-miR-667) were pseudotyped with VSV-G
protein and generated using a standardized protocol with highly
purified plasmids and EndoFectin-Lenti and TiterBoost reagents
(GeneCopoeia Inc). The lentiviral transfer vector (pEZX-MR03)
was cotransfected into 293Ta cells (catalog No. CLv-PK-01) with
Lenti-Pac HIV packaging mix (catalog No.: HPK-LvTR-20). The
lentivirus particles were purified and stored at -80˚C in aliquots
(purified particles). Full-length sequencing, restriction enzyme
digestion, and PCR size validation using gene-specific and
vector-specific primers were used to validate the lentiviral
expression construct. Lentiviral particles were injected sub-
cutaneously into the plantar surface of the left hind paw (12 mL
total) using custom-designed small hub 30-gauge Hamilton
needles at a concentration of 1.45 3 109 transduction units (TU)
per milliliter. The TU of the lentiviral particles was estimated using
the following formula: 1 TU 5 100 copies of viral genomic RNA.
Mice of both sexes (outbred CD-1 [ICR:Crl]) were obtained
from Charles River (Boucherville, QC, Canada). For formalin
testing, mice were placed on a tabletop within Plexiglas cylinders
(30 cm high and 15 cm diameter) and allowed to habituate. Then,
20 mL of 1% formalin was injected subcutaneously into the
plantar surface of the left hind paw using a 100-mL microsyringe
with a 30-gauge needle. Mice were then returned to the cylinders
and left undisturbed for 60 minutes, with behaviors recorded
using a digital video camera. Videos were later coded offline,
where the first 10 seconds of every minute was monitored for the
presence of licking/biting (positive sample) of the left hind paw for
a total of 60 observations. The early phase was defined as the
percentage of positive samples during the first 0 to 10 minutes
after injection of formalin; the late phase as the percentage of
positive samples during the period 10 to 60 minutes after
injection. Formalin testing was conducted 21 days after injection
of the lentiviral miRNAs.
3. RESULTS
3.1. Affymetrix microarray data reveal differential mRNA
expression in the coding and 39-UTR regions in the Comt1
and the ComtB2i mouse strains
Gene expression data were collected from 7mouse brain regions
(prefrontal cortex, amygdala, hypothalamus, hippocampus,
nucleus accumbens, striatum, and pituitary gland) of the 29
mouse strains carrying either the ancestral (Comt1) or the B2
SINE insertion (ComtB2i) alleles. Consistent with previous reports,
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Figure 1.Microarray hybridization pattern of coding vs 39-UTR regions for mouseComtmRNAexpressed by 29Comt1andComtB2imouse inbred lines. (A) The Affymetrix
array reveals bimodal Comt expression hybridization patterns in coding (left) vs 39-UTR (right) regions. Each bar represents the z score of 1 inbred line. Inbred mouse lines
carrying the ancestral allele,Comt1 (white bars), have greater mRNA hybridization signal in the 39-UTR than in the coding region, whereas strains carrying theComtB2i allele
(black bars) have the opposite hybridization profile in both female (top) andmale (bottom) animals. The representative expression profile of prefrontal cortex is presented; see
Supplementary Figures 1 to 4 for other brain regions. (B) Schematics of the ancestral (Comt1, top) and of the 2 alternative (ComtB2i, middle and bottom) allelic transcripts
showing the coding and 39-UTR array target regions, theB1 andB2SINE transposons, and the ancestral (black star) and alternative (grey star) PASs. The alternativeComtB2i
allele can generate both a full-length transcript containing B2SINE transposon sequence (middle) and a shorter transcript that ends after theB2SINE-inserted PAS (bottom).
(C) Sequence of PAS hexamers and frequency found in themouse genome, reported by Tian et al.59 (D) Sequence of the full-lengthComtB2i transcript withmarkedB2SINE
and B1 transposons, as well as the ancestral and alternative PASs.
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mouse strains carrying the ComtB2i allele showed higher levels of
ComtmRNA than Comt1 animals when mRNA was measured in
the coding region of the transcript27,56; the opposite expression
profile was noted for the 39-UTR region, where ComtB2i animals
showed less mRNA than strains carrying the Comt1 allele
(Fig. 1A, Supplementary Figures 1-4, available online as
Supplemental Digital Content at http://links.lww.com/PAIN/
A116). The B2 SINE insertion carries a strong PAS (Fig. 1B),
AATAAA, which is duplicated to AATAAATAAA. The AATAAA is
the most frequently used PAS in mouse genome (Fig. 1C), and
considering the duplication of this signal, the probability of using
this PAS is very high. Furthermore, the AATAAA PAS signal is
followed by a less frequent PAS mouse signal, TTTAAA, both of
which are in part of the B2 SINE sequence (Fig. 1D). The results
of 39RACE experiments suggested that these PASs are used in
vivo.24 Utilization of these PASs leads to the expression of
a substantially shorter Comt mRNA transcript than the ancestral
one. The switched expression pattern was seen in all tested brain
regions in both male and female mice (Fig. 1A, Supplementary
Figures 1-4, available online as Supplemental Digital Content at
http://links.lww.com/PAIN/A116) measured by the Affymetrix
array, and this difference was statistically significant in virtually all
7 tested brain regions (Supplementary Table 2, available online as
Supplemental Digital Content at http://links.lww.com/PAIN/
A116). These results suggest that both full-length and shorter
mRNA isoforms are expressed in ComtB2i mouse strains with
higher prevalence of the latter, and the effect of the B2 SINE
insertion is identical for both males and females. Our results also
demonstrate lower overall Comt expression in female mice
(Supplementary Table 2, available online as Supplemental Digital
Content at http://links.lww.com/PAIN/A116), which is consistent
with previous reports for both mice and humans,33,50 and is due
to estrogen downregulation of Comt expression in females.66
3.2. Comt expression constructs reveal polyadenylation
signal selectivity
We designed Comt expression vectors with either the ancestral
39-UTR (pComt1) or the 39-UTR containing the B2 SINE insertion
(pComtB2i; Fig. 2A). The pComtB2i constructs showed greater
COMT enzymatic activity in different cell lines (Supplementary
Figure 5, available online as Supplemental Digital Content at
http://links.lww.com/PAIN/A116), which was in agreement with
the previously reported higher Comt enzymatic activity from
Figure 2. Comparison of expression levels of Comt1 and ComtB2i transcripts in vivo and in vitro. (A) The pComt1 construct has the entire ancestral sequence of
Comt transcript (NM_001111063); the pComtB2i construct contains the same entire sequencewith the B2SINE insertion; the pComtB2i No 39-UTR has the sequence
after themajor PASwithin the B2 SINE removed. (B) In vivoComtmRNA expression levels in the PFC ofComt1 andComtB2i female andmale animalsmeasured in
the coding and 39-UTR regions. Z scores show thatComtB2i animals have significantly higher expression level thanComt1 animals whenComt is measured in the
coding region, and significantly lower expression levels when Comt is measured in the 39-UTR. (C) In vitro ComtmRNA expression levels in cells transfected with
pComt1 or one of the 2 pComtB2i constructs measured in the coding and 39-UTR regions. Z scores show that transfections with the pComtB2i construct result in
higher expression level than with the pComt1whenComt is measured in the coding region; in contrast with in vivo results, whenComt is measured in the 39-UTR,
transfection with the pComtB2i or the pComt1 construct results in similar expression levels. The pComtB2i No 39-UTRmimics the shorter alternativeComtB2i transcript
in the mouse generated by utilization of the alternative PAS, and transfection with it results in higher expression level than that of pComt1whenComt is measured
in the coding region. Significance is denoted as * for P , 0.05, ** for P , 0.01, and ***for P , 0.0001.
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ComtB2i brain lysates.50 The mRNA levels in our cell transfection
experiments reflected our in vivo observations to a certain extent.
The in vivo results indicated lower mRNA levels in Comt1 animals
when targeting the coding region, and higher mRNA levels when
targeting the 39-UTR region of Comt, as compared with ComtB2i
animals, andmeasured by the overall Z score ofComt expression
level across 7 different brain regions (Fig. 2B). The pattern of
expression is virtually identical in both males and females,
confirming that the effect of the B2 SINE insertion is the same
for both males and females, regardless of baseline expression
levels (Fig. 2B). The in vitro experiments were in the same
direction, with a significant, although weaker, difference in mRNA
levels: the pComtB2i construct showed higher mRNA levels when
targeting the coding region but no significant difference in mRNA
levels when targeting the 39-UTR region compared with the
pComt1 construct (Fig. 2C). The fold difference in the levels of
mRNA in the coding region for pComtB2i vs pComt1 constructs
was more modest than in ComtB2i vs Comt1 animals. We then
hypothesized that the B2 SINE–inserted PAS was not used as
efficiently in the in vitro system. To test if the shorter Comt
mRNA is more stable than full size, we created a new construct,
ComtB2i No 39-UTR, in which we truncated the pComtB2i plasmid
after the B2 SINE PAS (Fig. 2A). This construct showed
significantly higher mRNA levels than the pComt1 construct in
the coding region, as we predicted. The COMT enzymatic activity
of this construct was also in line with mRNA levels (Supplemen-
tary Figure 5D, available online as Supplemental Digital Content at
http://links.lww.com/PAIN/A116). Together, these data led us to
propose the existence of regulatory elements in the 39-UTR of
Comt contributing to RNA stability.
3.3. Early polyadenylation signal eliminates microRNA
target regions
To find miRNA targets that may have been lost by the early PAS in
the ComtB2i transcripts, we analyzed the 39-UTR Comt region
immediately upstream of the later PAS of the full Comt transcript
and downstream of the predicted PAS at the end of the B2 repeat
region. We selected 3 miRNA targets from the list of top predicted
targets: mmu-miR-667-3p, mmu-miR-667-5p, and mmu-miR-
3470a/b (Fig. 3). All these targets are located in the predominantly
unpaired regions. Both mature miRNAs, mmu-miR-667-3p and
mmu-miR-667-5p, derived from original mmu-miR-667 precursor
miRNA, are relatively unique in the mouse genome/transcriptome
and could not be masked by a RepeatMasker search.52
Furthermore, mmu-miR-667 is the only candidate situated in the
area of interest whose targets are in the list of top 3 predicted
miRNA target sites with P , 0.001, as predicted by the miRWalk
program (Supplementary Table 3, available online asSupplemental
Digital Content at http://links.lww.com/PAIN/A116). miRNAs
mmu-miR-3470a/b recognize the same site within the 39-UTR of
Comt mRNA, mapped in the rodent-specific B1 repeat region,
and located close to the end of the longest known transcript
(Fig. 3). Because mmu-miR-3470a and mmu-miR-3470b are
located within B1 transposon sequence, their targets are
extensively dispersed throughout the genome and cannot be
considered unique on a transcriptome level. Because most of
the repeat regions have the ability to interact and form highly
stable duplexes, the free energy threshold is higher for repeats
and different algorithms should be applied for searching these
areas.23,36
We next analyzed the conservation of miRNA targets. We only
compared rodent genomes, becausemmu-miR-667 is annotated
only in mouse and rat genomes, and the target for mmu-miR-
3470a/b is also located within the rodent-specific B1 transposon in
the miRbase database. We found that the seed regions of mmu-
miR-667-3p and -5p targetswere substantially conserved between
mouse and rat (Supplementary Figure 6, available online as
Supplemental Digital Content at http://links.lww.com/PAIN/A116)
in the 39-UTR of the Comt1 transcript. Furthermore, the target of
mmu-miR-3470a and mmu-miR-3470b is also extremely well
conserved betweenmouse and rat because of its location in theB1
transposon (Supplementary Figure 6, available online as Supple-
mental Digital Content at http://links.lww.com/PAIN/A116).
Thus, we selected miRNAs mmu-miR-667-3p, mmu-miR-
667-5p,mmu-miR-3470a, andmmu-miR-3470b asmost reliable
candidates to investigate which miRNA could differentially
regulate full but not truncated Comt transcripts, taking into
account that their target accessibility is high, display favorable
free-energy duplex formation profiles within seed regions, exhibit
high conservation, and are located within our area of interest.
3.4. Regulation of ancestral Comt by 3 microRNA in murine
RAW cells
To provide evidence that ancestral Comt levels can be regulated
by the identified miRNA targets absent in the truncated isoform,
we transfected murine RAW cells with the ancestral pComt1
construct, a normalizing vector, and an expression vector
containing the precursor for one of the 3miRNAs. The expression
vector for mmu-miR667 produces both species mmu-miR-667-
3p and mmu-miR-667-5p. As determined by RT-PCR, Comt
mRNA levels measured in the coding region were significantly
decreased by the miRNA constructs pmiR 3470a (P , 0.0001)
and pmir 3470b (P , 0.05) and were also decreased by pmiR
667, almost reaching significance (P 5 0.0578) (Fig. 4A). Comt
enzymatic activity was significantly decreased by all 3 miRNAs
(Fig. 4B). These results demonstrate that both mRNA and
enzymatic activity ofmurine ancestral but not truncatedComt can
be downregulated bymmu-miR-667,mmu-miR-3470a, ormmu-
miR-3470b miRNAs.
3.5. Correlation of endogenous microRNAs and Comt
transcript levels in mouse brain
To provide evidence that ancestral Comt transcript level is
regulated by the identified miRNA targets in vivo, we measured
the transcript level of both theComt coding region and each of the
3 miRNAs in individual mouse brain regions: hippocampus,
hypothalamus, and amygdala. A new separate cohort of male
AKR/J andBALB/cByJ (ComtB2i strains) andC3H/HeJ andSJL/J
(Comt1 strains) mice were purchased and tested. We observed
a significant negative correlation betweenmmu-miR-667-3p and
Comt transcripts inComtB2i andComt1 animals (Fig. 5B). Neither
mmu-miR-667-5p, mmu-miR-3470a, nor mmu-mi-3470b was
significantly correlated with Comt transcript levels, although
a negative slope was observed for all miRNAs (Fig. 5A,
Supplementary Fig. 7A and B, available online as Supplemental
Digital Content at http://links.lww.com/PAIN/A116). These
results are in line with our in vitro findings on mmu-miR-667-3p
and further demonstrate that brain tissues expressing higher
levels of mmu-miR-667-3p express lower levels of Comt mRNA.
Together with our in vitro experiments, these results suggest
direct downregulation of Comt by mmu-miR-667-3p.
To investigate potential molecular processes underlying the
association between mmu-miR-667-3p and Comt mRNA levels,
but not mmu-miR-667-5p, mmu-miR-3470a, and mmu-miR-
3470b, we estimated the relative abundance of all 4 miRNAs in
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different mouse tissues. We used a data set of differential tissue-
specific miRNA expression available from Chiang et al.7 We
observed that the mean relative expression ofmmu-miR-667-3p
miRNAs across all tissues, including brain, was 20 times higher
than the mean relative expression of mmu-miR-667-5p (Supple-
mentary Table 4, available online as Supplemental Digital Content
at http://links.lww.com/PAIN/A116 and Fig. 5C). The relative
expressions ofmmu-miR-3470a andmmu-miR-3470bwere 4 to
10 times lower than relative expression of mmu-miR-667-3p
(Supplementary Tables 5 and 6, and Supplementary Figure 7C,
available online as Supplemental Digital Content at http://links.
lww.com/PAIN/A116). Although this difference is not as high as
mmu-miR-667-5p, the location ofmmu-miR-3470a/b targets within
the B1 repeat region would further deplete their effective miRNA
concentration because of its wide distribution throughout the
mouse genome. Thus, mmu-miR-667-3p has a much higher
relative expression, and therefore, can more efficiently influence
relative level of ComtmRNA that is generally highly expressed in
the brain.
3.6. Modulation of pain responses by lentiviral
microRNA injections
To confirm that mmu-miR-3470a, mmu-miR-3470b, and mmu-
miR-667 modulate pain responses in vivo, we subcutaneously
injected the miRNAs into the plantar surface of the foot using
lentiviral vectors. Outbred CD-1mice were used because they do
not have a B2 SINE insertion and thus have full-length 39-UTR of
Comt mRNA and thus targets for selected miRNAs. We chose to
inject the virus peripherally because there is a substantial
difference in Comt contribution to modulation of pain sensitivity
through peripheral vs spinal adrenergic signalling. Nociceptive,
inflammatory, and musculoskeletal pain seems to be driven by
peripheral adrenergic receptor stimulation, and lower Comt
activity is hyperlagesic.49
The complete time course for all formalin testing is shown in
Fig. 6A. After formalin injection, mmu-miR-3470a was the only
miRNA that significantly increased immediate licking behaviour
(Fig. 6B). However, in the late tonic phase (10-60 minutes) of the
formalin test, all 3 miRNAs significantly increased licking
behaviour when compared with an injection of scrambled cDNA
(Fig. 6B). This demonstrates that, at least peripherallymmu-miR-
3470a, mmu-miR-3470b, and mmu-miR-667 increase hyper-
sensitivity during tonic inflammatory pain states, which is
consistent with reduced Comt activity.
4. Discussion
Investigation of functional genetic variants, such as the B2 SINE
insertion, that regulate gene expression and function continues to
be one ofmost challenging aspects of human genetic studies and
related animal models. First, the discovery of truly functional
Figure 3.PredictedmiRNA sites andprofile of free energyof target accessibility in the 39-UTRof themurineComtgene. (A) Alignment of the 3predictedmurinemiRNA
target positions to the 39-UTR of Comt1 and location of ancestral PAS (black star); (B) alignment of the 3 predicted murine miRNA target positions to the 39-UTR of
ComtB2i and location of the ancestral PAS (black star) and alternative PAS (gray star), when the full transcript is made inComtB2i animals; (C) when the alternative PAS
(gray star) is used inComtB2i animals, the 3 predictedmiRNA target sites formmu-miR-667-3/-5 andmmu-miR-3470a/b are absent; (D) target locations formmu-miR-
667-3p (in red),mmu-miR-667-5p (in green), for mmu-miR-3470a ormmu-miR-3470b (in yellow) and their respective free energy (kcal/mol).
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genetic variants, but not their markers, assures that association
patterns will be stable in future studies and allows for practical use
of these genetic variants if needed, for example, in diagnostic
testing. Second, a deep understanding of the exact order of
molecular and cellular events connecting sequence alteration at
a gene locus with alteration of protein function provides the ability
to intervene in the process, leading to an ultimate understanding
of the pathophysiology of genetic variability and ability to modify
the pathological phenotypes.
Genetic variability in the COMT gene locus in both human and
mouse has been reproducibly associated with multiple pheno-
types. A reduced activity allele of human COMT64 has been
implicated in an assortment of diseases and personality traits, such
as obsessive–compulsive disorder,46 attention-deficit hyperactivity
Figure 5.Correlation between relativemRNA expression levels ofComt andmmu-miR-667-3p ormmu-miR-667-5p. (A andB) RT-PCR results were generated on
the independent cohort of 4 mouse strains: AKR/J and BALB/cByJ (ComtB2i strains), and C3H/HeJ and SJL/J (Comt1 strains). Relative ComtmRNA levels were
measured in the coding region and plotted against relative miRNA levels from the same sample. Each data point represents a single mouse from theComtB2i (red)
or Comt1 (blue) strains. Results show (A) a strong negative correlation between increasing amounts of mmu-miR-667-3p and decreasing amounts of Comt
transcript and (B) no correlation between amounts of mmu-miR-667-5p and Comt transcript. (C) RNA-seq read coverage of the mature mmu-miR-667-5p and
mmu-miR-667-3p in mouse tissues and cell lines. The number of reads per million (RPM) of assessed mouse tissues (brain, testis, ovary, spleen, bone marrow,
skin, and salivary glands) and cell line is presented.7
Figure 4. Effect of cell transfection with eachmiRNA expression construct onComtmRNA expression levels and enzymatic activities. The pComt1 construct was
cotransfected with pSEAP and either pmiR-Empty Vector, pmiR-667, pmiR-3470a, or pmiR-3470b;ComtmRNA expression was measured in the coding region,
and SEAP activity was used for normalization of transfection efficiency. (A) Comt mRNA expression levels and (B) enzymatic activity in each transfected sample
were compared with that of pComt1 cotransfected with pmiR-Empty Vector. Transfection with all miRNAs downregulated mRNA expression level and enzymatic
activity, although the downregulation of mRNA expression by miR-667 did not reach significance (P 5 0.0578). Significance is denoted as * for P , 0.05, ** for
P , 0.01.
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disorder,10,44,47 disproportionate anxiety response,14,15,17,21,39,54
mood,3 working memory,57 and cognition.16,32 In mouse labora-
tory strains, a B2 SINE insertion has been associated with stress
response and anxiety behaviors.24,29,50 Furthermore, COMT
seems to be one of the major contributors to variation in sensitivity
to noxious stimuli and pathological pain states.2,11,22,40,56,67
Previously, the molecular genetic mechanisms of human COMT
gene locus variability have been well studied,13,41,42 but the
molecular genetic mechanisms whereby a SINE insertion in the 39-
UTR of mouse Comt affects the activity of the enzyme remained
unknown.
De novo insertions of repeat elements into the human genome
commonly result in negative outcomes.1 The contribution of
repeat elements into alterations of gene function has not been as
well characterized in mouse. It is estimated that 37.5% of the
mouse genome is made up of transposable elements (SINEs,
LINEs, and other interspersed repeat elements), with 1% being
SINEs.8 The B2 SINE has been the most extensively studied, with
publications listing its effects on transcription, alternative splicing,
and evolution.6,26,38,48 However, the B2 SINE insertion inComt is
the first description of a repeat element upregulating gene
expression, rather than downregulating it.
In studying the molecular genetic mechanism of the SINE-
dependentComtmRNA upregulation, we first tested whether the
SINE insertion promotes alternative mRNA splicing by providing
an early PAS in the Comt gene locus, and if this shorter mRNA is
more stable. Analysis of cDNA array data showed that bothComt
mRNAs, the full-length and shorter isoforms, are expressed in
ComtB2i mouse strains, with preference for the shorter isoform.
Our in vitro studies using expression vectors with cloned Comt
cDNAwith andwithout the SINE insertion (pComtB2i and pComt1
constructs, respectively) showed that the difference in the levels
of shorter and longer isoforms expressed by pComtB2i construct
is even smaller. However, the plasmid construct with no 39-UTR
after the SINE insertion shows very high stability. These data
provide evidence that even when the SINE-derived earlier PAS is
used only partially, the short mRNA isoform is much more stable
and contributes significantly to the overall increase in mRNA
levels of Comt in ComtB2i mouse strains.
Frequently, changes in mRNA levels reflect the impact of
miRNAs on gene expression and indicate that destabilization of
target mRNAs is the predominant reason for reduced protein
output.19 These recent findings drove us to identify potential
miRNA targets. Specifically, we searched for potential silencing
signals in the sequence between the early PASwithin the B2 SINE
insertion and the later PAS in the Comt1 39-UTR using
computational target prediction approaches.35,36,43,51
We then tested if ancestral Comt level can be regulated by the
identified miRNA targets absent in the truncated Comt isoform
both in vitro and in vivo. Our in vitro results demonstrated that
bothmRNA and enzymatic activity of murine ancestralComt can
be downregulated by mmu-miR-667, mmu-miR-3470a, or
mmu-miR-3470b miRNAs. Interestingly, mmu-miR-667
showed much more robust downregulation of COMT protein
level than mRNA level, suggesting that mmu-miR-667 may
control not only the level of Comt mRNA stability but also the
translational efficiency. Although the latter mechanism of
miRNA-dependent gene expression regulation is not the main
one, it has been observed previously. Recent studies on
ribosome profiling demonstrated that approximately 16% of
the decrease in protein production is not accounted for by
lowered mRNA levels in both ectopic and endogenous miRNA
regulatory interactions.19 Furthermore, it is interesting to note
that transfection of all 3 miRNAs expression constructs leads to
substantial biological outcomes on the transfected cells, such
as intense cell growth. Whether the latter effect is related to an
alteration in Comt levels or it is driven by other target(s) of these
miRNAs is a subject for future studies.
We also correlated mRNA levels of Comt and each of the 4
miRNAs in individual mouse brains regions. Interestingly, only
mmu-miR-667-3p showed a significant negative correlation
with Comt levels. These data only partially support our in vitro
results, which indicated that all 3 miRNA targets have functional
effects by downregulating Comt mRNA level. However, taking
into account our results on downstream estimation of endog-
enous expression levels of all miRNAs in mouse brain tissues,
we would suggest that the absence of in vivo correlation
between the levels of mmu-miR-667-5p, mmu-miR-3470a,
mmu-miR-3470b miRNAs, and Comt mRNA is not evidence
that thesemiRNA targets are not functional. Rather, it maymean
that the ComtmRNA and miRNA levels were not in comparable
ranges in the tested tissues and animals, so that these miRNAs
could not regulate Comt mRNA at these conditions. There may
be other tissues or conditions in whichmmu-miR-667-5p,miR-
3470a, and miR-3470b miRNAs would be able to regulate the
level of Comt mRNA. Finally, our results of lentiviral injections of
Figure 6. Intraplantar injection ofmmu-miR-667,mmu-miR-3470a, andmmu-miR-3470b increases hypersensitivity on the formalin assay of nocifensive behavior.
(A) The time course data for licking in the formalin test are presented for day 21 post-miRNA intraplantar injection. (B) The averaged data for the early (0-10minutes)
and late (10-60 minutes) phases of the formalin test are shown. Onlymmu-miR-3470a increased licking during the early phase; however, all 3 miRNAs increased
licking during the late phase of the assay when compared with scrambled cDNA (scr cDNA). Statistical analyses were performed using a 1-way ANOVA and
compared all groups on either the early or late phase separately; n5 8 per group. Significance is denoted as * for P, 0.05, ** for P, 0.01, and *** for P, 0.0001.
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mmu-miR-3470a, mmu-miR-3470b, and mmu-miR-667 dem-
onstrate that all 3 miRNAs increase hypersensitivity during tonic
inflammatory pain states in the mouse formalin model,
suggesting that in vivo induction of all tested miRNAs down-
regulates Comt mRNA level.
The identification of the molecular mechanism whereby an
alternative allele that is common in laboratory mice regulates
Comt function advances our understanding of basic biological
processes and has implication for human genetics. First, it is
clear that the molecular genetic mechanisms of COMT
functional variation are highly diverse. All functional human
COMT allelic variants affect COMT activity through a multitude
of unique mechanisms, such as regulation of mRNA stability,4
protein stability,31 or secondary and tertiary mRNA structures.41,61
And yet, mouse functional genetic variation regulates Comt activity
through another mechanism that has no reported analogy in
humans. This suggests that functional molecular genetic studies
will likely continue to be challenging and low throughput. Second,
the presence of functional miRNA target sites in the 39-UTR of
mouseComtwarrants the search for functional miRNA target sites
in the 39-UTR of human COMT. In fact, our data show that even
partial removal of the 39-UTR carrying these targets yields
substantial increases in ComtmRNA stability and protein amount.
Considering that these regulatory sites are most likely to be
conserved in evolution, they are of great significance and can play
an important role in regulation of human COMT.
An additional translational component of this study lies in its
contribution to the ongoing debate regarding the role of COMT in
disorders such as anxiety and pain. Our mouse studies describe
the molecular mechanism of a newly discovered allele of Comt
function as an elegant proof-of-concept for diseases of cate-
cholamine dysregulation. Evidence from monkey to human
suggests that there is a strong correlation between the pro-
gressive increase in catecholamines with a concurrent increase in
working memory, anxiety disorders, and pain conditions.45 The
domesticated mice with the B2 SINE insertion are a reflecting
mirror of the effects of low catecholamines on the same
processes and represent a new animal model of the effects of
genetic quantitative regulation of Comt and catechol load on
Comt-dependent traits, including pain.
In summary, we demonstrated that the presence of the B2
SINE insertion allows utilization of an alternative PAS within
a significant subpopulation of mRNA molecules, creating an
alternative Comt mRNA with a shorter 39-UTR. This alternatively
spliced Comt mRNA does not carry targets for mmu-miR-667
and mmu-miR-3470a/b miRNAs, which downregulate both
Comt mRNA stability and protein synthesis. Our study reveals
a newmolecular mechanismwherebyComt level and activity can
be regulated through miRNAs and explains how the B2 SINE
insertion eliminates naturally accruing degradation signals,
leading to an increase in COMT protein levels.
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